News

Replimune faces FDA challenges for RP1's approval in advanced melanoma, highlighting complexities in cancer drug development and regulatory scrutiny.

Topical ruxolitinib, phototherapy, and psychosocial care took center stage in an interactive discussion between Seemal Desai, MD, FAAD, and colleagues, on managing complex vitiligo cases.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At a recent Dermatology Times Case-Based Roundtable event, Stephanie Simmerman, DNP, APRN-C, discussed treatment selection, access challenges, and more for patients with vitiligo.

According to new research from Steven Dayan, MD, FACS, PROs are reshaping aesthetic medicine, enhancing Botox treatment insights and prioritizing holistic patient care.

Bristol Myers Squibb's deucravacitinib gains global regulatory acceptance for treating active psoriatic arthritis, promising a new oral treatment option.

The 2025 Fall Clinical Dermatology Conference energized PAs and NPs with innovative strategies, addressing burnout, digital branding, and personalized medicine.

Johnson & Johnson submitted an NDA for icotrokinra, a promising new treatment for moderate to severe plaque psoriasis in adults and adolescents.

A retrospective case series found that apremilast induced complete remission in 6 men with treatment-resistant genital psoriasis.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the launch of deuruxolitinib for alopecia areata, Treg cel impairment in vitiligo, the top aesthetic innovations of this month, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New research highlights the significant impact of dermatological diseases on work-life balance, revealing greater burdens for women compared to men.

The dermatology community mourns the loss of Dr. Robert Sidbury, a visionary leader in pediatric dermatology, whose impact and mentorship resonate deeply.

Elderly patients show lower and more mild patch test reactivity than younger individuals, with different sensitization patterns.

Global acne burden in reproductive-age women has risen significantly, with greater increases expected by 2040.

Experts share how this year's RAD Conference showcased cutting-edge advancements in atopic dermatitis to enhance patient care and treatment strategies.

Hershel Dobkin, MD, FAAD, shares his experiences and the surprising reasons behind clinic delays, from patient needs to unexpected moments.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Jacki Kment, PA-C, MPAS, DFAAPA, shares how she built a successful direct pay dermatology practice to prioritize patient care and professional balance.

New survey data reveals gaps in atopic dermatitis treatment for pregnant women, highlighting the need for updated guidelines and better physician education.

Rigorous pre-, intra-, and postoperative protocols help ensure safe, effective periocular laser treatments and reduce the risk of ocular complications.

Abrocitinib significantly improves lesion severity and pruritus in moderate to severe AD, offering a promising treatment option for patients.

Our July cover story explores effective treatments for hidradenitis suppurativa, including procedural interventions and advanced therapies that enhance patient quality of life.

Art transforms dermatology by fostering dialogue, enhancing patient connection, and challenging biases, as medical students explore creative expression in health care.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

With longer visits and flat-rate pricing, Kment’s practice provides personalized dermatologic care to both insured and uninsured patients.